Evaluating of BRCA1 and BRCA2 Germ-line mutations and BRCA risk assessment of mutation carriers in Turkish breast cancer patients
dc.contributor.buuauthor | Çeçener, Gülşah | |
dc.contributor.buuauthor | Egeli, Ünal | |
dc.contributor.buuauthor | Tunca, Berrin | |
dc.contributor.buuauthor | Ertürk, Elif | |
dc.contributor.buuauthor | Gökgöz, Şehsuvar | |
dc.contributor.buuauthor | Taşdelen, İsmet | |
dc.contributor.buuauthor | Ak, Seçil | |
dc.contributor.buuauthor | Demirdoğen, Elif | |
dc.contributor.buuauthor | Tezcan, Gülçin | |
dc.contributor.buuauthor | Bayram, Nuran | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Genel Cerrahi Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/İktisadi ve İdari Bilimler Fakültesi/Ekonometri Bölümü. | tr_TR |
dc.contributor.orcid | 0000-0002-3820-424X | tr_TR |
dc.contributor.orcid | 0000-0001-5492-184X | tr_TR |
dc.contributor.orcid | 0000-0001-7904-883X | tr_TR |
dc.contributor.orcid | 0000-0002-1619-6680 | tr_TR |
dc.contributor.researcherid | AAG-9068-2021 | tr_TR |
dc.contributor.researcherid | AAH-1420-2021 | tr_TR |
dc.contributor.researcherid | AAK-3371-2021 | tr_TR |
dc.contributor.researcherid | AAH-3843-2020 | tr_TR |
dc.contributor.researcherid | ABI-6078-2020 | tr_TR |
dc.contributor.researcherid | F-8554-2017 | tr_TR |
dc.date.accessioned | 2022-04-11T06:17:36Z | |
dc.date.available | 2022-04-11T06:17:36Z | |
dc.date.issued | 2012-07 | |
dc.description | Bu çalışma, 07-10 Haziran 2012 tarihleri arasında Barcelona[İspanya]’da düzenlenen 22. Biennial Congress of the European-Association-for-Cancer-Research’da bildiri olarak sunulmuştur. | tr_TR |
dc.description.sponsorship | European Assoc Canc Res | en_US |
dc.identifier.citation | Çeçener, G. vd. (2012). "Evaluating of BRCA1 and BRCA2 Germ-line mutations and BRCA risk assessment of mutation carriers in Turkish breast cancer patients". European Journal of Cancer, 48(Supplement 5), S105-S105. | en_US |
dc.identifier.endpage | S105 | tr_TR |
dc.identifier.issn | 0959-8049 | |
dc.identifier.issue | Supplement 5 | en_US |
dc.identifier.startpage | S105 | tr_TR |
dc.identifier.uri | https://doi.org/10.1016/S0959-8049(12)71114-0 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0959804912711140 | |
dc.identifier.uri | http://hdl.handle.net/11452/25683 | |
dc.identifier.volume | 48 | tr_TR |
dc.identifier.wos | 000313036500397 | |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | CPCIS | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.journal | European Journal of Cancer | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Oncology | en_US |
dc.subject.wos | Oncology | en_US |
dc.title | Evaluating of BRCA1 and BRCA2 Germ-line mutations and BRCA risk assessment of mutation carriers in Turkish breast cancer patients | en_US |
dc.type | Meeting Abstract | |
dc.wos.quartile | Q1 | en_US |